Smart drug choice: matching pills to your heart type may beat standard BP care
NCT ID NCT07240909
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests whether choosing blood pressure medication based on a person's specific heart and blood vessel measurements (hemodynamic phenotyping) works better than the usual guideline-based approach. About 240 adults with mild-to-moderate hypertension who have never taken blood pressure drugs will receive either a personalized drug (amlodipine, metoprolol, or indapamide) or standard treatment for 8 weeks. The goal is to see if the personalized method leads to greater blood pressure reduction with similar safety.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
amlodipine, metoprolol, or indapamide
What this could lead to
If it works, this could show that matching blood pressure drugs to a person's specific heart and blood vessel type leads to better blood pressure control than the usual one-size-fits-all approach.
What could go wrong
This is a relatively small, early-phase trial (240 people) that hasn't started yet. The personalized approach may not prove better than standard care, and results may not apply to everyone with hypertension.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.